ES469016A1 - Un procedimiento para la preparacion de alfa1 timosina - Google Patents

Un procedimiento para la preparacion de alfa1 timosina

Info

Publication number
ES469016A1
ES469016A1 ES469016A ES469016A ES469016A1 ES 469016 A1 ES469016 A1 ES 469016A1 ES 469016 A ES469016 A ES 469016A ES 469016 A ES469016 A ES 469016A ES 469016 A1 ES469016 A1 ES 469016A1
Authority
ES
Spain
Prior art keywords
group
glu
formation
preparation
thr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES469016A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/871,563 external-priority patent/US4116951A/en
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES469016A1 publication Critical patent/ES469016A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57581—Thymosin; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ES469016A 1977-04-22 1978-04-21 Un procedimiento para la preparacion de alfa1 timosina Expired ES469016A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78989877A 1977-04-22 1977-04-22
US05/871,563 US4116951A (en) 1977-04-22 1978-01-23 [Asn2 ]-thymosin α1 and analogs thereof

Publications (1)

Publication Number Publication Date
ES469016A1 true ES469016A1 (es) 1980-01-01

Family

ID=27120967

Family Applications (1)

Application Number Title Priority Date Filing Date
ES469016A Expired ES469016A1 (es) 1977-04-22 1978-04-21 Un procedimiento para la preparacion de alfa1 timosina

Country Status (18)

Country Link
JP (1) JPS53137914A (en:Method)
AT (1) AT364470B (en:Method)
CA (1) CA1113088A (en:Method)
CH (3) CH641152A5 (en:Method)
DE (1) DE2817082A1 (en:Method)
DK (1) DK147918C (en:Method)
ES (1) ES469016A1 (en:Method)
FI (1) FI781241A7 (en:Method)
FR (2) FR2401134A1 (en:Method)
GB (1) GB1590668A (en:Method)
GR (1) GR71886B (en:Method)
HU (1) HU180783B (en:Method)
IT (1) IT1113134B (en:Method)
LU (1) LU79488A1 (en:Method)
NL (1) NL7804364A (en:Method)
NO (2) NO781404L (en:Method)
PT (1) PT67937B (en:Method)
SE (1) SE447262B (en:Method)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4116951A (en) * 1977-04-22 1978-09-26 Hoffmann-La Roche Inc. [Asn2 ]-thymosin α1 and analogs thereof
DE2919592A1 (de) * 1979-05-15 1981-01-15 Max Planck Gesellschaft Verfahren zur herstellung von thymosin- alpha 1 und derivaten davon
EP0033384B1 (de) * 1980-01-18 1984-02-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Thymosin-alpha-1-Fragmente enthaltende Arzneimittel mit immunstimulierender Wirkung, und Thymosin-alpha-1-Fragmente
US4339427A (en) * 1980-04-14 1982-07-13 Hoffmann-La Roche Inc. Radioimmunoassay of thymosinα
EP0056594B1 (de) * 1981-01-14 1984-09-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Thymosin-alpha-1-Fragmente enthaltende Arzneimittel mit immunregulierender Wirkung und Thymosin-alpha-1-Fragmente
CN1058500C (zh) * 1993-02-03 2000-11-15 施塞克龙药品公司 胸腺素α－1衍生物
US6262230B1 (en) * 1994-01-28 2001-07-17 Sciclone Pharmaceuticals Inc. Analogs of thymosin α1

Also Published As

Publication number Publication date
DK147918C (da) 1985-08-19
DK147918B (da) 1985-01-07
JPS53137914A (en) 1978-12-01
SE447262B (sv) 1986-11-03
NO781404L (no) 1978-10-24
PT67937B (en) 1980-04-07
NO821608L (no) 1978-10-24
CH640218A5 (en) 1983-12-30
FR2405926B1 (en:Method) 1983-09-09
DE2817082A1 (de) 1978-11-02
NO148924B (no) 1983-10-03
IT1113134B (it) 1986-01-20
ATA286178A (de) 1981-03-15
HU180783B (en) 1983-04-29
NL7804364A (nl) 1978-10-24
CH641153A5 (en) 1984-02-15
PT67937A (en) 1978-05-01
DK169478A (da) 1978-10-23
FR2405926A1 (fr) 1979-05-11
NO148924C (no) 1984-01-11
FR2401134A1 (fr) 1979-03-23
AT364470B (de) 1981-10-27
GB1590668A (en) 1981-06-03
CA1113088A (en) 1981-11-24
IT7822629A0 (it) 1978-04-21
LU79488A1 (de) 1979-05-25
GR71886B (en:Method) 1983-08-04
CH641152A5 (en) 1984-02-15
FR2401134B1 (en:Method) 1983-09-30
SE7804612L (sv) 1978-12-20
FI781241A7 (fi) 1978-10-23

Similar Documents

Publication Publication Date Title
KR850003417A (ko) 폴리펩티드의 제조방법
ATE170875T1 (de) Analoge vom menschlichen insulin
GB1487717A (en) Diagnostic agent for the detection of protein in body fluids
AU578722B2 (en) Fluid spacer composition for use in well cementing
PT1100529E (pt) A timosina beta 4 promove a preparacao de feridas
DE68905633D1 (de) Markierer der t-zelle aktivierung.
KR850008681A (ko) 합성펩티드의 제조방법
GR900100513A (en) Reinforced compositions for the release of peptides soluble in water
DK0883687T3 (da) C-C CKR-5, CC-chemokinreceptor, derivater deraf og anvendelse deraf
GB1516947A (en) Hentricontapeptides
ZA921230B (en) Improved activation of recombinant proteins
IT1123007B (it) Canotto pneumatico in special modo per uso su fiumi o acque in corrente
ATE181961T1 (de) Neue wasserlösliche polypeptide mit hoher affinität für alpha- und beta- interferone
KR840007569A (ko) Grf 유사체 펩티드의 제법
DE3261304D1 (en) Retro-inverso analogues of c-terminal penta and hexapeptides of substance p.
DE69018926D1 (de) Vakzine gegen Bordetella.
EP0161007A3 (en) Retro - inverso c-terminal hexapeptide analogues of substance p
Luedke et al. Map showing distribution, composition, and age of Late Cenozoic volcanic centers in Oregon and Washington
AU659866B2 (en) Probe system for performing HLA DR typing and typing method using said probes
ES2076933T3 (es) Nuevos sustratos peptidicos.
ES2144392T3 (es) Vectores de expresion para la sintesis de proteinas en la levadura de escision schizosaccharomyces pombe.
PT67937A (en) Process for the preparation of thymosin alpha and or analogue.
Kumar et al. Phenomenon of crack branching
JPS5328165A (en) Peptide derivatives and measurement of collagenase activity using peptide derivatives
JPS6470577A (en) Modified polybutene-based hot-melt composition

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19991102